Keirnan Willett
- Ophthalmology top 0.5%
- Retinal Diseases and Treatments 6
- Retinal and Optic Conditions 2
-
- Retinopathy of Prematurity Studies 3
- Corneal Surgery and Treatments 2
- Neurology top 5%
- Molecular Biology top 10%
- Retinal Development and Disorders 5
- Biochemistry top 5%
-
- Virus-based gene therapy research 3
-
- Neonatal Respiratory Health Research 3
-
- Herpesvirus Infections and Treatments 3
- Co-authors
- Lois E. H. SmithKip M. ConnorChristopher M. AdermanJing ChenAndreas StahlRoberta J. DennisonPrzemysław SapiehaNathan M. Krah
- Partner nations
- United StatesGermanySweden
In The Last Decade
Keirnan Willett
21 papers receiving 2.1k citations
Hit Papers
Peers
Comparison fields: 5 of 88
- Ophthalmology 914
- Radiology, Nuclear Medicine and Imaging 720
- Neurology 151
- Molecular Biology 1.2k
- Biochemistry 114
Countries citing papers authored by Keirnan Willett
This map shows the geographic impact of Keirnan Willett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keirnan Willett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keirnan Willett more than expected).
Fields of papers citing papers by Keirnan Willett
This network shows the impact of papers produced by Keirnan Willett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keirnan Willett. The network helps show where Keirnan Willett may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Keirnan Willett, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 0 | |
| 2 | 2022 | 1 | |
| 3 | 2022 | 11 | |
| 4 | 2021 | 9 | |
| 5 | 2020 | 9 | |
| 6 | Intranasal delivery of resveratrol nanoparticles reduces retinal ganglion cell loss in a model of multiple sclerosis | 2020 | 3 |
| 7 | 2019 | 1 | |
| 8 | Smartphone Ophthalmoscopy (D-Eye System) for Detection of Optic Nerve Pathology and Cup-to-Disc Ratio in an Outpatient Clinical Setting | 2017 | 1 |
| 9 | 2016 | 113 | |
| 10 | 2013 | 72 | |
| 11 | 2012 | 56 | |
| 12 | 2011 | 202 | |
| 13 | 2011 | 107 | |
| 14 | 2010 | 23 | |
| 15 | 2010 | 80 | |
| 16 | 2009 | 144 | |
| 17 | 2009 | 119 | |
| 18 | Quantification of oxygen-induced retinopathy in the mouse: a model of vessel loss, vessel regrowth and pathological angiogenesisbreakdown → | 2009 | 590 |
| 19 | 2009 | 63 | |
| 20 | 2000 | 51 |
About Keirnan Willett
Keirnan Willett is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Neurology, having authored 22 papers that have together received 2.2k indexed citations. Recurring topics across this work include Retinal Diseases and Treatments (6 papers), Retinal Development and Disorders (5 papers), Virus-based gene therapy research (3 papers), Neonatal Respiratory Health Research (3 papers), Herpesvirus Infections and Treatments (3 papers), Retinopathy of Prematurity Studies (3 papers), Corneal Surgery and Treatments (2 papers) and Retinal and Optic Conditions (2 papers). The work is most often cited by research in Ophthalmology (914 citations), Radiology, Nuclear Medicine and Imaging (720 citations) and Neurology (151 citations). Keirnan Willett has collaborated with scholars based in United States, Germany and Sweden. Frequent co-authors include Lois E. H. Smith, Kip M. Connor, Christopher M. Aderman, Jing Chen, Andreas Stahl, Roberta J. Dennison, Przemysław Sapieha, Nathan M. Krah, Karen I. Guerin and Molly R. Seaward. Their work appears in journals such as Circulation, PLoS ONE and Circulation Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.